ArticleiScience2025

DIRAS3-derived cyclic peptides disrupt KRAS-RAF interaction and KRAS nanoclustering, suppressing KRAS-driven pancreatic and ovarian tumors.

Joshua P Gray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.